On 12 December 2021, IVASS published Discussion Paper No. 1 of 2022 on the Preliminary Considerations for future regulatory interventions by IVASS on life products. The Considerations, as indicated above, start from the requests for adjustment of ISVAP Regulation No. 38/2011, as amended by Measure No. 68/2018, which allows undertakings to provide for methods of […]
UPDATES






